Taisho Pharmaceutical Holdings Co., Ltd.
OTC: TAISF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Akira Uehara
- Employees
- 8,784
- Headquarters
- Tokyo, Japan
- IPO year
- 2023
- Market cap
- $118.0
- Website
- https://www.taisho-holdings.co.jp
Loading TAISF…
Loading profile data…Frequently asked questions about TAISF
What does Taisho Pharmaceutical Holdings Co., Ltd. (TAISF) do?
Taisho Pharmaceutical Holdings Co., Ltd., headquartered in Tokyo, Japan, is a long-established global pharmaceutical company, founded in 1912. The company and its subsidiaries are comprehensively involved in the research, development, manufacturing, marketing, and distribution of both over-the-counter (OTC) consumer health products and prescript...
Where does TAISF trade?
Taisho Pharmaceutical Holdings Co., Ltd. (TAISF) trades on the Other OTC.
What sector is TAISF in?
Taisho Pharmaceutical Holdings Co., Ltd. (TAISF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Taisho Pharmaceutical Holdings Co., Ltd.?
Akira Uehara is the chief executive officer of Taisho Pharmaceutical Holdings Co., Ltd. (TAISF).
Where is Taisho Pharmaceutical Holdings Co., Ltd. headquartered?
Taisho Pharmaceutical Holdings Co., Ltd. is headquartered in Japan.
Does TAISF pay a dividend?
Yes — Taisho Pharmaceutical Holdings Co., Ltd. (TAISF) paid a trailing twelve-month dividend of USD 0.74 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TAISF go public?
Taisho Pharmaceutical Holdings Co., Ltd. (TAISF) completed its initial public offering in 2023.